NPR reported on October 30, 2026, that clinical trials of Ebola vaccines have begun in the Democratic Republic of the Congo. According to NPR, the trials target the Bundibugyo species of the Ebola virus.

NPR's Scott Detrow spoke with Dr. Meg Doherty, director of science for health at the World Health Organization, about the trials, NPR said in its report, which is available on NPR's website. The report was written by Tinbete Ermyas.

NPR's summary of that conversation does not say how many people are enrolled in the trials, name the trial sites, or state when the trials began. It also does not include Doherty's specific comments on the trials' progress or results, so those points cannot be confirmed from this account.

The report's headline, "Ebola vaccine trials begin in DRC," states that the trials have started, and the summary describes the trials as aimed at the Bundibugyo species. NPR's two descriptions do not conflict, and the summary does not describe any disagreement among sources.

NPR's summary identifies Doherty's role at the World Health Organization but does not describe any further role the agency has in the trials beyond the interview itself. Because this account rests on a single NPR report, it does not include information from other outlets, health officials, or trial documents.

Sources: NPR: Ebola vaccine trials begin in DRC.